Heparin-independent mitogenicity in an endothelial and smooth muscle cell chimeric growth factor (S130K-HBGAM)
Authors:
- Howard P. GreislerHGHoward P. Greisler
- 1 November 2004
- journal article
- research article
- Published by Elsevier in The American Journal of Surgery
- Vol. 188 (5) , 575-579
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Mechanism of Late In-Stent Restenosis After Implantation of a Paclitaxel Derivate–Eluting Polymer Stent System in HumansCirculation, 2002
- Histopathologic Alterations after Endovascular Radiation and Antiproliferative Stents: Similarities and DifferencesHerz, 2002
- The S130K fibroblast growth factor–1 mutant induces heparin-independent proliferation and is resistant to thrombin degradation in fibrin glueJournal of Vascular Surgery, 2000
- Inhibition of Rat Smooth Muscle Proliferation by Radiation after Arterial Injury: Temporal CharacteristicsIn VivoandIn VitroRadiation Research, 2000
- Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: A 9-year experienceSurgery, 1999
- Structure of a heparin-linked biologically active dimer of fibroblast growth factorNature, 1998
- Analysis of Putative Heparin-binding Domains of Fibroblast Growth Factor-1Journal of Biological Chemistry, 1995
- Selective stimulation of endothelial cell proliferation with inhibition of smooth muscle cell proliferation by fibroblast growth factor-1 plus heparin delivered from fibrin glue suspensions*Surgery, 1995
- Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biological half‐lifeJournal of Cellular Physiology, 1989
- Current Status of Vascular GraftsSurgical Clinics of North America, 1982